Skip to content

Non-invasive Brain Stimulation in Adults Who Stutter

Non-invasive Brain Stimulation in Adults Who Stutter

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03437512
Enrollment
29
Registered
2018-02-19
Start date
2018-06-25
Completion date
2020-04-01
Last updated
2021-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stuttering, Developmental

Keywords

transcranial direct current stimulation, MRI, Speech, fluency, tDCS

Brief summary

Research studies in stuttering have shown that activity patterns in certain brain areas differ in people who stutter compared to people who do not stutter when speaking. The purpose of this study is to investigate how mild, non-invasive brain stimulation applied consecutively for five days affects speech relevant brain areas, which may in turn affect speech fluency and speaking-related brain activity in people who stutter.

Interventions

DEVICEAnodal tDCS

20 minutes of 2mA anodal stimulation.

Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes

DEVICESham tDCS

For sham stimulation, current is ramped up and back down over 30 seconds.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

A researcher who is not involved in any aspect of the study will randomize participants into the sham and active study arms using a minimization procedure. Allocation concealment will be achieved by assigning a unique 6-digit random code per participant, which will be provided to the researcher. The code is used to deliver stimulation. The participants and the researchers who deliver stimulation, assess outcomes, and analyze data will be masked to trial arm.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* history of persistent developmental stuttering * stuttering severity ranging from mild to very severe, specifically Stuttering Severity Instrument (SSI) total score of 20 (mild) or higher and stuttering rates of 3% or higher * scores within 1 standard deviation of the norm on the standardized tests for the study

Exclusion criteria

* received any treatment for stuttering within the past year * other neurological conditions such as Tourette's syndrome or post-traumatic stress disorder * taking any medications/drugs that affect brain function * history of past or current mental illness for example, schizophrenia that may affect brain development and function * history of serious medical or neurological illness such as epilepsy and Parkinson's disease * history of closed head injury (e.g., concussion) * history of reading disorders * hearing loss * taking any medication, prescription or non-prescription with any psychotropic effects at the time of the study * metal or electronic implants such as cochlear implants, and pacemakers

Design outcomes

Primary

MeasureTime frameDescription
Changes in Brain Activation as Assessed by fMRI ImagesBaseline, 1 week (post), 4 weeks (follow up)Investigators will use the fMRI images taken from before and after tDCS to determine if the treatment intervention contributed to any changes within brain regions associated with speech production. This will be measured by Blood-Oxygen-Level-Dependent (BOLD) signal change (arbitrary units). Images from scans are preprocessed. Changes in BOLD signal are modeled for contrasts within a group for \[post-pre\] and \[follow up-pre\] (e.g., active group reading condition post visit MINUS active group reading pre visit). Results are reported for reading condition.
Change in Percentage of Stuttered Syllables Produced During Speech SampleBaseline, 1 week (post), 4 weeks (follow up)Investigators will calculate the percentage of stuttered syllables (out of total syllables) in a speech sample. Decreased stuttered syllables represents better outcomes (greater reduction in stuttering).

Secondary

MeasureTime frameDescription
Changes From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)Baseline, 1 week (post), 4 weeks (follow up)The OASES is a standardized assessment of the functional impact of stuttering on a person's life. There are 4 sub-tests: general information about speech, your reactions to stuttering, communication in daily situations, quality of life. Each one has a score from 1 to 5 with regard to impact (1 least, 5 most negative impact). These are combined to give a total impact score between 1 and 5, with 5 representing the highest negative impact on person's life. The change on the total impact score will be used. Changes are shown in the table below by comparison between the measurements at the three points in time.

Other

MeasureTime frameDescription
Changes From Baseline on Rhythm Judgement TaskBaseline, 1 week, 4 weeksInvestigators will compare performance accuracy on a computerized rhythm judgement task from before and after tDCS to assess effects of tDCS. Improved accuracy reflects better performance.
Changes From Baseline on Tapping TasksBaseline, 1 week, 4 weeksInvestigators will compare performance on computerized tapping tasks from before and after tDCS to assess effects of tDCS.
Changes From Baseline on Self-rated Measure of Speech FluencyBaseline, 1 week, 4 weeksInvestigators will compare participant scores on a self-rated measure of speech fluency (1 = NO STUTTERING; 9 = EXTREMELY SEVERE STUTTERING) from before and after tDCS to assess effects of tDCS. Lower scores indicate improvement.

Countries

United States

Participant flow

Pre-assignment details

Participants were required to meet a certain stuttering severity status. Four participants who were enrolled did not meet the pre-assignment criteria and were thus not assigned to an arm.

Participants by arm

ArmCount
Active tDCS and Fluency Training
Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days). Anodal tDCS: 20 minutes of 2mA anodal stimulation. Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
12
Sham tDCS and Fluency Training
Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days). Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes Sham tDCS: For sham stimulation, current is ramped up and back down over 30 seconds.
11
Total23

Withdrawals & dropouts

PeriodReasonFG000FG001
Completed Study Follow upCould not complete study due to COVID-19 research pause21
RandomizedWithdrawal by Subject02

Baseline characteristics

CharacteristicActive tDCS and Fluency TrainingSham tDCS and Fluency TrainingTotal
Age, Continuous27.43 years
STANDARD_DEVIATION 8.14
23.31 years
STANDARD_DEVIATION 2.87
25.46 years
STANDARD_DEVIATION 6.54
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants11 Participants22 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Overall Assessment of Speaker's Experience of Stuttering2.48 score on a scale
STANDARD_DEVIATION 0.58
2.67 score on a scale
STANDARD_DEVIATION 0.68
2.57 score on a scale
STANDARD_DEVIATION 0.64
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Asian
2 Participants1 Participants3 Participants
Race (NIH/OMB)
Black or African American
2 Participants1 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
7 Participants8 Participants15 Participants
Sex: Female, Male
Female
2 Participants1 Participants3 Participants
Sex: Female, Male
Male
10 Participants10 Participants20 Participants
Stuttering Severity5.66 percent
STANDARD_DEVIATION 3.23
9.72 percent
STANDARD_DEVIATION 8.88
7.69 percent
STANDARD_DEVIATION 6.06

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 11
other
Total, other adverse events
12 / 1210 / 11
serious
Total, serious adverse events
0 / 120 / 11

Outcome results

Primary

Change in Percentage of Stuttered Syllables Produced During Speech Sample

Investigators will calculate the percentage of stuttered syllables (out of total syllables) in a speech sample. Decreased stuttered syllables represents better outcomes (greater reduction in stuttering).

Time frame: Baseline, 1 week (post), 4 weeks (follow up)

ArmMeasureGroupValue (MEAN)Dispersion
Active tDCS and Fluency TrainingChange in Percentage of Stuttered Syllables Produced During Speech Sample% Change follow up-1.03 percent change in stuttered syllablesStandard Deviation 4.17
Active tDCS and Fluency TrainingChange in Percentage of Stuttered Syllables Produced During Speech Sample% Change post-1.82 percent change in stuttered syllablesStandard Deviation 2.22
Sham tDCS and Fluency TrainingChange in Percentage of Stuttered Syllables Produced During Speech Sample% Change post1.06 percent change in stuttered syllablesStandard Deviation 2.02
Sham tDCS and Fluency TrainingChange in Percentage of Stuttered Syllables Produced During Speech Sample% Change follow up3.46 percent change in stuttered syllablesStandard Deviation 5.47
Comparison: Analyses conduced with a mixed ANOVA, with between-subjects factor of group (active, sham) and two within-subjects factors: time (post, follow up) and speech task (reading, conversation).p-value: 0.936ANOVA
Primary

Changes in Brain Activation as Assessed by fMRI Images

Investigators will use the fMRI images taken from before and after tDCS to determine if the treatment intervention contributed to any changes within brain regions associated with speech production. This will be measured by Blood-Oxygen-Level-Dependent (BOLD) signal change (arbitrary units). Images from scans are preprocessed. Changes in BOLD signal are modeled for contrasts within a group for \[post-pre\] and \[follow up-pre\] (e.g., active group reading condition post visit MINUS active group reading pre visit). Results are reported for reading condition.

Time frame: Baseline, 1 week (post), 4 weeks (follow up)

Population: One subject assigned to the sham condition did not want to participate in the MRI but participated in every other aspect of the study. Additionally, 2 subjects assigned to active and 1 assigned to sham did not complete follow up MRI due to pandemic research pause. The MRI data from one subject in the active arm was corrupted and therefore not analyzable and was excluded from MRI results. Therefore \[post-pre\] includes 11 active and 10 sham, whereas \[follow up-pre\] includes 9 active and 9 sham.

ArmMeasureGroupValue (MEAN)Dispersion
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft supplementary motor area (SMA) (post-pre)1.39 Percent signal changeStandard Deviation 0.45
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft SMA (fol-pre)1.03 Percent signal changeStandard Deviation 0.49
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright SMA (post-pre)-0.45 Percent signal changeStandard Deviation 0.48
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright SMA (fol-pre)0.86 Percent signal changeStandard Deviation 0.54
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft superior temporal gyrus (STG) (post-pre)1.43 Percent signal changeStandard Deviation 0.74
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft STG (fol-pre)0.09 Percent signal changeStandard Deviation 0.53
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright STG (post-pre)-0.63 Percent signal changeStandard Deviation 0.97
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright STG (fol-pre)0.3 Percent signal changeStandard Deviation 1.07
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft putamen (post-pre)1.37 Percent signal changeStandard Deviation 0.66
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft putamen (fol-pre)2.42 Percent signal changeStandard Deviation 0.71
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright putamen (post-pre)-1.01 Percent signal changeStandard Deviation 0.65
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright putamen (fol-pre)0.89 Percent signal changeStandard Deviation 0.69
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft inferior frontal gyrus (IFG) (post-pre)1.6 Percent signal changeStandard Deviation 0.94
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft IFG (fol-pre)0.23 Percent signal changeStandard Deviation 0.96
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright IFG (post-pre)-0.48 Percent signal changeStandard Deviation 0.8
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright IFG (fol-pre)-0.2 Percent signal changeStandard Deviation 0.8
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft premotor cortex (PMC) (post-pre)1.33 Percent signal changeStandard Deviation 0.91
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft PMC (fol-pre)0.68 Percent signal changeStandard Deviation 0.96
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright PMC (post-pre)0.31 Percent signal changeStandard Deviation 0.72
Active tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright PMC (fol-pre)1.32 Percent signal changeStandard Deviation 1.01
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft PMC (fol-pre)0.62 Percent signal changeStandard Deviation 1.11
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft supplementary motor area (SMA) (post-pre)0.81 Percent signal changeStandard Deviation 0.47
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright putamen (post-pre)-0.74 Percent signal changeStandard Deviation 0.67
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft SMA (fol-pre)0.9 Percent signal changeStandard Deviation 0.54
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright IFG (fol-pre)-0.2 Percent signal changeStandard Deviation 0.8
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright SMA (post-pre)0.49 Percent signal changeStandard Deviation 0.52
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright putamen (fol-pre)0.06 Percent signal changeStandard Deviation 0.86
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright SMA (fol-pre)0.09 Percent signal changeStandard Deviation 0.35
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright PMC (fol-pre)1.01 Percent signal changeStandard Deviation 1.17
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft superior temporal gyrus (STG) (post-pre)0.79 Percent signal changeStandard Deviation 0.75
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft inferior frontal gyrus (IFG) (post-pre)-0.33 Percent signal changeStandard Deviation 0.97
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft STG (fol-pre)0.57 Percent signal changeStandard Deviation 0.85
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft premotor cortex (PMC) (post-pre)-0.15 Percent signal changeStandard Deviation 1.67
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright STG (post-pre)1.56 Percent signal changeStandard Deviation 1.39
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft IFG (fol-pre)0.14 Percent signal changeStandard Deviation 0.74
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright STG (fol-pre)0.83 Percent signal changeStandard Deviation 1.17
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright PMC (post-pre)1.2 Percent signal changeStandard Deviation 0.93
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft putamen (post-pre)-0.31 Percent signal changeStandard Deviation 0.58
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesright IFG (post-pre)0.11 Percent signal changeStandard Deviation 0.65
Sham tDCS and Fluency TrainingChanges in Brain Activation as Assessed by fMRI Imagesleft putamen (fol-pre)-0.22 Percent signal changeStandard Deviation 0.59
p-value: <0.001t-test, 2 sided
Secondary

Changes From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)

The OASES is a standardized assessment of the functional impact of stuttering on a person's life. There are 4 sub-tests: general information about speech, your reactions to stuttering, communication in daily situations, quality of life. Each one has a score from 1 to 5 with regard to impact (1 least, 5 most negative impact). These are combined to give a total impact score between 1 and 5, with 5 representing the highest negative impact on person's life. The change on the total impact score will be used. Changes are shown in the table below by comparison between the measurements at the three points in time.

Time frame: Baseline, 1 week (post), 4 weeks (follow up)

ArmMeasureGroupValue (MEAN)Dispersion
Active tDCS and Fluency TrainingChanges From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)Pre2.48 score on a scaleStandard Deviation 0.61
Active tDCS and Fluency TrainingChanges From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)Post2.34 score on a scaleStandard Deviation 0.55
Active tDCS and Fluency TrainingChanges From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)Follow up2.35 score on a scaleStandard Deviation 0.57
Sham tDCS and Fluency TrainingChanges From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)Pre2.67 score on a scaleStandard Deviation 0.75
Sham tDCS and Fluency TrainingChanges From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)Post2.56 score on a scaleStandard Deviation 0.78
Sham tDCS and Fluency TrainingChanges From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)Follow up2.59 score on a scaleStandard Deviation 0.88
p-value: 0.619ANOVA
Other Pre-specified

Changes From Baseline on Rhythm Judgement Task

Investigators will compare performance accuracy on a computerized rhythm judgement task from before and after tDCS to assess effects of tDCS. Improved accuracy reflects better performance.

Time frame: Baseline, 1 week, 4 weeks

Other Pre-specified

Changes From Baseline on Self-rated Measure of Speech Fluency

Investigators will compare participant scores on a self-rated measure of speech fluency (1 = NO STUTTERING; 9 = EXTREMELY SEVERE STUTTERING) from before and after tDCS to assess effects of tDCS. Lower scores indicate improvement.

Time frame: Baseline, 1 week, 4 weeks

Other Pre-specified

Changes From Baseline on Tapping Tasks

Investigators will compare performance on computerized tapping tasks from before and after tDCS to assess effects of tDCS.

Time frame: Baseline, 1 week, 4 weeks

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026